I am interested in method development in several areas: identification of precision therapeutics for patients with rare genetic diseases, integration of multimodal data to improve diagnostic accuracy in cases of obscure illness, and evaluation of hematologic disorders via integrated interpretation of histopathologic, flow cytometric, and protein electrophoretic data. I am also interested in the development of novel electrophoretic techniques and informatics-based approaches to diagnosing and monitoring clonal gammopathies.
